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This Month in the Journal
Mutations in BRCA2, by Edwards et al. (p. 1)
Studies of families with breast cancer have suggested that
male carriers of at least some BRCA2 mutations are at
increased risk of prostate cancer at early ages. To further
examine the contribution of this gene to prostate cancer,
Edwards et al. ascertained a sample of individuals who
were diagnosed with prostate cancer when younger than
56 years of age. These men were screened for BRCA2
mutations; six truncating mutations, as well as 22 var-
iants of unknown significance, were found. Of the six
men with truncating mutations, only one had a family
history of prostate cancer, whereas two had a family
history of breast or ovarian cancer. Thus, there were
BRCA2-associated prostate cancer cases with no family
history of breast or ovarian cancer. These results suggest
that BRCA2 mutations may be responsible for a signif-
icant fraction of early-onset prostate cancer, even in fam-
ilies without a history of breast and ovarian cancer.
CRYM Mutations in Nonsyndromic Deafness, by Abe
et al. (p. 73)
Congenital deafness is a genetically heterogeneous dis-
order. Although several genes for deafness have been
identified, there are many more deafness loci for which
no gene has been cloned. Rather than starting with ge-
netic linkage data to identify additional deafness genes,
Abe et al. decided to identify candidate genes using mi-
croarrays to identify those that are highly expressed in
the inner ear. They looked for transcripts that were
highly expressed in cochlear and vestibular tissue, rel-
ative to a mix of several other tissues. As a proof of
principle, nine genes known to be involved in nonsyn-
dromic deafness were included in the array, and ex-
pression in the inner ear was confirmed for seven of these
genes in the experiment. In fact, the gene with the highest
relative expression in the inner ear was COCH, which
is involved in autosomal dominant nonsyndromic hear-
ing loss. The authors decided to focus on CRYM, the
gene with the second highest relative expression in the
inner ear. DNA sequence of this gene in 192 patients
with nonsyndromic hearing loss identified two individ-
uals with mutations, a missense mutation, and a mu-
tation of the stop codon. Aberrant localization of both
variant proteins in transfected cells supports their clas-
sification as mutants, but this awaits confirmation in
additional families affected with deafness.
 2003 by The American Society of Human Genetics. All rights reserved.
0002-9297/2003/7201-0001$15.00
FGF14 Mutation in Dominant Ataxia, by van Swieten
et al. (p. 191)
Several different loci are known to be involved in the
hereditary spinocerebellar ataxias (SCA). Disease-asso-
ciated mutations in the SCA genes are almost all tri- or
pentanucleotide expansions. Now, van Swieten et al. re-
port a rare point mutation associated with an SCA phe-
notype. This mutation, a missense change in the gene
for fibroblast growth factor 14 (FGF14), was found in
a large family with early-onset tremor, dyskinesia, and
slowly progressive cerebellar ataxia that was not due to
any of the previously known SCA loci. Protein modeling
predicts that this mutation would destabilize the en-
coded protein. Further supporting the involvement of
this mutation in the phenotype is the fact that Fgf14
knockout mice show an ataxic phenotype reminiscent
of the one seen in this family. At this point, little is known
regarding the function of FGF14, so its role in the de-
velopment of ataxia is unclear.
MSR1 Variants and Prostate Cancer Risk, by Xu et al.
(p. 208)
In a recent issue of Nature Genetics (32:321–325), Xu
et al. found six rare missense mutations and one non-
sense mutation in MSR1 that showed some association
with both hereditary and nonhereditary prostate cancer.
MSR1 encodes the macrophage scavenger receptor 1
protein, which is a macrophage-specific receptor that has
been implicated in a number of processes, including in-
flammation, oxidative stress, and immunity. In a follow-
up to this paper, Xu et al. examined five common var-
iants in MSR1 and found that they, too, are associated
with nonhereditary prostate cancer. None of the previ-
ously studied rare MSR1 mutations is found on the risk
haplotype containing the common MSR1 variants, so it
seems that their effects are independent. Although the
associations between MSR1 and prostate cancer have
been modest so far, the data suggest that commonMSR1
sequence variants may be associated with prostate can-
cer risk in the general population.
Association of IVF with BWS, by DeBaun et al. (p.
156) and Letter to the Editor, by Orstavik et al. (p.
218)
Over the past year, there has been a smattering of reports
suggesting that children conceived through use of as-
sisted reproductive technologies (ART) may be at in-
creased risk of low birth weight and birth defects. In
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this issue of the Journal, two additional articles add ev-
idence that intracytoplasmic sperm injection (ICSI) may
be associated with imprinting defects in children con-
ceived by this method. DeBaun et al. use data gathered
through the Beckwith-Wiedemann Syndrome (BWS) reg-
istry and estimate that there is a sixfold increase in BWS
in children born after ART compared with the general
population. All of the case subjects with BWS identified
in this study were conceived though ICSI. Imprinting
studies on DNA from these individuals indicate that five
of six children tested had abnormal imprinting of at least
one BWS-associated gene. Orstavik et al. also report a
sporadic imprinting defect in an individual whowas con-
ceived by ICSI and who has Angelman syndrome. BWS
and Angelman syndrome are rare disorders, making it
difficult to determine whether the apparently increased
rate of these syndromes in the ART sample is significant.
However, these data suggest that the risks of ART should
be studied further.
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